A Major Review Found THC Caused Cell Death in the Hippocampus and Shared Reward Pathways With Other Drugs of Abuse | Research

The takeaway

A comprehensive neurobiology review revealed that THC caused neuron shrinkage and DNA fragmentation in the hippocampus, activated the same dopamine reward pathways as morphine, alcohol, and nicotine, and produced cognitive deficits that persisted after withdrawal.

Read this if you want a comprehensive understanding of how cannabis affects the brain at the molecular, cellular, and behavioral levels.

THC activated the same mesolimbic dopamine reward pathway as morphine, alcohol, and nicotine

What the researchers found

This extensive review covered the full spectrum of cannabis effects on the brain, from molecular mechanisms to behavioral consequences.

A striking finding was that recent research had revealed THC-induced cell death in the hippocampus, with neuron shrinkage and DNA fragmentation, effects the review stated had been "underestimated for a long time." Cognitive deficits, particularly in concentration and memory, appeared to persist after withdrawal.

At the receptor level, the review detailed how CB1 receptors mediate THC's effects through G proteins, inhibiting calcium channels and stimulating potassium channels. The CB2 receptor, found in immune tissue, provided the molecular basis for immunosuppression.

Critically, the review established that cannabinoids increase dopaminergic neuron activity in the mesolimbic pathway, the same reward circuit activated by morphine, alcohol, and nicotine. This shared "final common pathway" was interpreted as underlying marijuana's reinforcing and abuse properties.

Why it matters

This review integrated the emerging understanding of cannabinoid neuroscience into a coherent picture for the first time: from receptor to cell death, from endocannabinoids to behavioral effects, from acute intoxication to withdrawal. The finding that cannabis shares a dopamine reward pathway with other drugs of abuse was particularly influential.

The numbers in context

CB1 and CB2 receptors described. CB1 highest in hippocampus, cerebellum, striatum. CB1 and CB2 share 44% nucleotide sequence identity. Two endocannabinoids detailed: anandamide and 2-AG.

How the study worked

Comprehensive narrative review published in Progress in Neurobiology, covering cannabinoid receptors, endocannabinoids, signaling mechanisms, neurotoxicity, cognitive effects, and reward pathways.

What this study cannot tell us

The hippocampal cell death findings were from animal studies with high-dose exposure and have been debated in subsequent research. The review's characterization of cannabis toxicity as "underestimated" reflects one interpretation of evolving evidence. The shared reward pathway does not necessarily mean cannabis has the same addiction potential as other substances.

How to read the evidence

A comprehensive review in a major neuroscience journal. Authoritative synthesis but some findings, particularly hippocampal cell death, have been debated in subsequent research.

When this study was published

Published in 1999. Some conclusions, particularly about neurotoxicity severity, have been refined by subsequent research. The shared reward pathway finding has been broadly confirmed.

The bigger picture

The mesolimbic dopamine pathway connection became a cornerstone of addiction neuroscience, supporting the reclassification of heavy cannabis use as a genuine substance use disorder rather than a benign habit. The hippocampal cell death findings, while controversial, shifted the conversation about cannabis neurotoxicity.

Questions still open

Do hippocampal cell death findings replicate at human-relevant doses? Does the shared dopamine pathway mean cannabis has similar addiction potential to other drugs? Are the persistent cognitive deficits truly permanent or do they eventually resolve?

Common questions

Does cannabis kill brain cells?

This review cited recent findings of THC-induced neuron shrinkage and DNA fragmentation in the hippocampus in animal studies. However, these findings used high doses and have been debated. The extent to which this occurs in human cannabis users remains uncertain.

Does cannabis activate the same reward pathways as other drugs?

Yes. The review established that cannabinoids increase dopamine activity in the mesolimbic pathway, the same reward circuit activated by morphine, alcohol, and nicotine.

Read the original research

The effects of cannabinoids on the brain.

Progress in neurobiology, 58(4), 315-48

View on PubMed ↗

Citation

Ameri, A. (1999). The effects of cannabinoids on the brain.. Progress in neurobiology, 58(4), 315-48.